bpc-157 diarrhea BPC 157 | Gastric Pentadecapeptide BPC-157 – Research Peptide |
Description
Oncotarget 7 , 7795877967 (2016)
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design
Visceral and liver fat reductions are material over time, alongside improving lipid panels and insulin
If you are dosing at 0.25 mg with the 5.0 mg/mL concentration, you are drawing only 5 units
So you can take whichever set of evidence you like," Hancock said
